(Q36926637)

17 August 2017

1 reference

title

Oral contraceptive steroids--pharmacological issues of interest to the prescribing physician (English)

1 reference

17 August 2017

Oral contraceptive steroids —pharmacological issues of interest to the prescribing physician (English)

1 reference

21 November 2022

author name string

M. Orme

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776556

21 November 2022

D. J. Back

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776556

21 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1776556

21 November 2022

publication date

1 December 1991

1 reference

full work available at URL

17 August 2017

http://link.springer.com/content/pdf/10.1007/BF02340178.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF02340178/fulltext.html

21 November 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF02340178

21 November 2022

1 reference

Advances in contraception : the official journal of the Society for the Advancement of Contraception

21 November 2022

published in

1 reference

17 August 2017

7

1 reference

17 August 2017

325-331

1 reference

17 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02340178

17 August 2017

0 references

cites work

The in vitro metabolism of ethinyloestradiol, mestranol and levonorgestrel by human jejunal mucosa

1 reference

https://api.crossref.org/works/10.1007%2FBF02340178

The gut wall metabolism of ethinyloestradiol and its contribution to the pre-systemic metabolism of ethinyloestradiol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02340178

Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02340178

Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive‐drug interactions with anticonvulsants and antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02340178

The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02340178

The effects of ampicillin on oral contraceptive steroids in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02340178

An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay

21 January 2018

1

1 reference

The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and Ovranette

21 November 2022

2

1 reference

Kinetics of norethindrone in women; I. Radioimmunoassay and concentrations during multiple dosing

21 November 2022

3

1 reference

Plasma concentrations of 3-keto-desogestrel after oral administration of desogestrel and intravenous administration of 3-keto-desogestrel

21 November 2022

4

1 reference

Interaction of ethinyloestradiol with ascorbic acid in man.

21 November 2022

7

1 reference

British Journal of Clinical Pharmacology

21 November 2022

9

22

217P

S.F.M. Grimmer

1986

1 reference

The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomy

21 November 2022

10

1 reference

Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis

21 November 2022

11

1 reference

Clinical Implications of Enzyme Induction and Enzyme Inhibition

21 November 2022

12

1 reference

The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women

21 November 2022

13

1 reference

The effect of rifampicin on norethisterone pharmacokinetics

21 November 2022

14

1 reference

Enzyme induction in the cytochrome P-450 system

21 November 2022

15

1 reference

Do Anticonvulsants Reduce the Efficacy of Oral Contraceptives?

21 November 2022

16

1 reference

The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy

21 November 2022

18

1 reference

The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids

21 November 2022

20

1 reference

The effect of antibiotics on the enterohepatic circulation of ethinylestradiol and norethisterone in the rat

21 November 2022

22

1 reference

Reduction of the enterohepatic circulation of norethisterone by antibiotics in the rat: correlation with changes in the gut flora

21 November 2022

23

1 reference

A study of interaction of low-dose combination oral contraceptive with Ampicillin and Metronidazole.

21 November 2022

24

1 reference

Interactions between oral contraceptive steroids and broad-spectrum antibiotics

21 November 2022

27

1 reference

The effect of cotrimoxazole on oral contraceptive steroids in women

21 November 2022

28

1 reference

The biliary and urinary metabolites of [3H]17 alpha-ethynylestradiol in women

21 November 2022

29

1 reference

21 November 2022

Identifiers

DOI

10.1007/BF02340178

1 reference

17 August 2017

1 reference